Novel approaches to treating Clostridium difficile-associated colitis
| Autor: | Padua, D, Pothoulakis, C |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Gastroenterology & Hepatology
Probiotics novel therapeutics Clinical Sciences Oncology and Carcinogenesis fecal microbial transplant Clostridium difficile Fecal Microbiota Transplantation Colitis Anti-Bacterial Agents Gastrointestinal Microbiome Intestines Treatment Outcome Bacterial Vaccines Clostridium Infections Animals Humans vaccine therapy |
| Zdroj: | Expert review of gastroenterology & hepatology, vol 10, iss 2 Padua, D; & Pothoulakis, C. (2015). Novel approaches to treating Clostridium difficile-associated colitis. Expert Review of Gastroenterology and Hepatology, 1-12. doi: 10.1586/17474124.2016.1109444. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1w43q6dd |
| Popis: | © 2015 Taylor & Francis Clostridium difficile is being recognized as a growing threat to many health-care systems. Epidemiology data shows that infection rates are soaring and the disease burden is increasing. Despite the efficacy of standard treatments, it is becoming evident that novel therapeutics will be required to tackle this disease. These new treatments aim to enhance the intestinal microbial barrier, activate the immune system and neutralize the toxins that mediate this disease. Many of these therapies are still in the beginning stages of investigation, however, in the next few years, more clinical data will become available to help implement many of these exciting new therapeutic approaches. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|